美国 · SEC FORM 4
CASTLE BIOSCIENCES INC
CSTL · Nasdaq · CIK 0001447362 · Healthcare · Diagnostics & Research
内部人信号
0 qualifying P purchase groups
当前 180 天评分窗口
138 同一窗口内观察到的 Form 4 交易行
109 sales · 29 期权、代扣税、授予、赠与或其他交易行
为什么没有活跃信号？
评分构成
活跃窗口内没有合资格买入，因此不计算分数。缺失的输入不会被当作零分或看空信号。
为什么没有分数？
- 没有合资格公开市场买入可提供聚集度、规模、角色、近期性或确信度输入。
- 卖出及其他 Form 4 活动继续作为背景显示，不会形成负分。
卖出和其他 Form 4 活动会单独显示，不会形成负面买入信号。没有买入不会被评分为看空。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
—
买方广度、集中度与聚集买入
合资格买入进入 180 天研究窗口后，这些模块才会启用。
信号历史
Scores are archived only when the company qualifies for a published US buy-signal snapshot. 最近一次合资格买入: 2023-06-05 · Goldberg Ellen.
近期 Form 4 活动
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
该股票尚未获取市场背景。每日任务会轮转处理美国股票池。
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 1,999,726
- 上期报告
- 1,899,369
- 日均成交量
- 419,633
- 回补天数
- 4.8
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
Form 4 申报证据
236 transaction lines in the latest 365-day window; 2,107 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Juvenal Tobin W | 卖出 (S) | Common Stock | 3,288 | USD 33.64 | USD 110,608 | SEC 申报 ↗ |
| 2026-10-05 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 14,496 | USD 35.57 | USD 515,565 | SEC 申报 ↗ |
| 2026-10-05 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 8,165 | USD 2.39 | USD 19,514 | SEC 申报 ↗ |
展开近期 Form 4 证据 (30 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | Juvenal Tobin W | 卖出 (S) | Common Stock | 3,288 | USD 33.64 | USD 110,608 | SEC 申报 ↗ |
| 2026-10-05 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 14,496 | USD 35.57 | USD 515,565 | SEC 申报 ↗ |
| 2026-10-05 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 8,165 | USD 2.39 | USD 19,514 | SEC 申报 ↗ |
| 2026-10-01 | Oelschlager Kristen M | 卖出 (S) | Common Stock | 4,153 | USD 35.95 | USD 149,318 | SEC 申报 ↗ |
| 2026-10-01 | Oelschlager Kristen M | 期权行权／转换 (M) | Common Stock | 4,153 | USD 3.38 | USD 14,037 | SEC 申报 ↗ |
| 2026-09-30 | Juvenal Tobin W | 卖出 (S) | Common Stock | 1,034 | USD 34.20 | USD 35,363 | SEC 申报 ↗ |
| 2026-09-29 | Juvenal Tobin W | 卖出 (S) | Common Stock | 5,543 | USD 35.50 | USD 196,765 | SEC 申报 ↗ |
| 2026-09-21 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 14,496 | USD 35.33 | USD 512,144 | SEC 申报 ↗ |
| 2026-09-21 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 8,580 | USD 2.39 | USD 20,506 | SEC 申报 ↗ |
| 2026-09-15 | Juvenal Tobin W | 卖出 (S) | Common Stock | 3,294 | USD 35.14 | USD 115,751 | SEC 申报 ↗ |
| 2026-09-14 | Juvenal Tobin W | 卖出 (S) | Common Stock | 3,306 | USD 32.32 | USD 106,850 | SEC 申报 ↗ |
| 2026-09-11 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 14,518 | USD 32.02 | USD 464,870 | SEC 申报 ↗ |
| 2026-09-11 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 8,584 | USD 2.39 | USD 20,516 | SEC 申报 ↗ |
| 2026-09-01 | Oelschlager Kristen M | 卖出 (S) | Common Stock | 4,152 | USD 33.39 | USD 138,643 | SEC 申报 ↗ |
| 2026-09-01 | Oelschlager Kristen M | 期权行权／转换 (M) | Common Stock | 4,152 | USD 3.38 | USD 14,034 | SEC 申报 ↗ |
| 2026-08-31 | Juvenal Tobin W | 卖出 (S) | Common Stock | 1,730 | USD 32.81 | USD 56,761 | SEC 申报 ↗ |
| 2026-08-28 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 17,726 | USD 33.20 | USD 588,448 | SEC 申报 ↗ |
| 2026-08-28 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 12,428 | USD 2.39 | USD 29,703 | SEC 申报 ↗ |
| 2026-08-25 | Juvenal Tobin W | 卖出 (S) | Common Stock | 9,050 | USD 35.04 | USD 317,112 | SEC 申报 ↗ |
| 2026-08-25 | Oelschlager Kristen M | 卖出 (S) | Common Stock | 12,384 | USD 34.42 | USD 426,261 | SEC 申报 ↗ |
| 2026-08-24 | Oelschlager Kristen M | 卖出 (S) | Common Stock | 12,218 | USD 33.69 | USD 411,624 | SEC 申报 ↗ |
| 2026-08-17 | Juvenal Tobin W | 卖出 (S) | Common Stock | 1,730 | USD 29.59 | USD 51,191 | SEC 申报 ↗ |
| 2026-08-14 | Stokes Frank | 卖出 (S) | Common Stock | 24,908 | USD 29.77 | USD 741,511 | SEC 申报 ↗ |
| 2026-08-14 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 6,398 | USD 30.02 | USD 192,068 | SEC 申报 ↗ |
| 2026-08-14 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 1,100 | USD 2.39 | USD 2,629 | SEC 申报 ↗ |
| 2026-08-05 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 3,575 | USD 30.68 | USD 109,681 | SEC 申报 ↗ |
| 2026-08-05 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 2,546 | USD 2.39 | USD 6,085 | SEC 申报 ↗ |
| 2026-08-04 | MAETZOLD DEREK J | 卖出 (S) | Common Stock | 35,441 | USD 31.11 | USD 1,102,657 | SEC 申报 ↗ |
| 2026-08-04 | MAETZOLD DEREK J | 期权行权／转换 (M) | Common Stock | 20,356 | USD 2.39 | USD 48,651 | SEC 申报 ↗ |
| 2026-08-03 | Oelschlager Kristen M | 卖出 (S) | Common Stock | 8,586 | USD 29.77 | USD 255,622 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | CSTL |
| CIK | 0001447362 |
| 行业 | Healthcare |
| 细分行业 | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 2,107 transaction lines from 2020-01-28 to 2026-10-12 5 P purchase lines · 1,845 S sale lines · 257 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.